Legato Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.32M | Sell |
11,602
-7,956
| -41% | -$904K | 0.16% | 209 |
|
|
2025
Q1 | $2.06M | Buy |
19,558
+1,500
| +8% | +$158K | 0.28% | 96 |
|
|
2024
Q4 | $1.93M | Buy |
18,058
+753
| +4% | +$80.7K | 0.25% | 111 |
|
|
2024
Q3 | $1.73M | Buy |
17,305
+3,185
| +23% | +$319K | 0.21% | 147 |
|
|
2024
Q2 | $1.19M | Buy |
14,120
+11,001
| +353% | +$927K | 0.16% | 212 |
|
|
2024
Q1 | $228K | Buy |
3,119
+144
| +5% | +$10.5K | 0.03% | 528 |
|
|
2023
Q4 | $212K | Buy |
+2,975
| New | +$212K | 0.03% | 522 |
|